Silence Therapeutics Company

Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.

Founded Date: 1999
Technology: Data-driven Technologies
Funding Status: IPO
Employee Number: 11-50
Headquarters: London, England, United Kingdom
Estimated Revenue: Less than $1M
Industry: PharmTech